Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spiriva Respimat in Cystic Fibrosis
NCT01179347Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2010
- Primary completion
- Mar 2012
- Countries
- 20
01
Overview
A Phase 3 trial of tiotropium in cystic fibrosis (CF), sponsored by Boehringer Ingelheim. Started Sep 2010; status: completed.
02
Drugs
tiotropium
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01179347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01179347.